LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | BI-2536 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1015 | 4513 | 0.2250 | -0.0672 |
MDA-MB-231 | BMS345541 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3687 | 4513 | 0.8170 | 0.7480 |
MDA-MB-231 | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 489 | 4513 | 0.1083 | -0.2279 |
MDA-MB-231 | GDC-0980 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2022 | 4513 | 0.4480 | 0.2398 |
MDA-MB-231 | NVP-AEW541 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4603 | 4513 | 1.0199 | 1.0275 |
MDA-MB-231 | SB590885 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4197 | 4513 | 0.9299 | 0.9034 |
MDA-MB-231 | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4209 | 4513 | 0.9325 | 0.9071 |
MDA-MB-231 | KIN001-043 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3573 | 4513 | 0.7916 | 0.7130 |
MDA-MB-231 | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4274 | 4513 | 0.9469 | 0.9269 |
MDA-MB-231 | Luminespib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 833 | 4513 | 0.1846 | -0.1228 |
MDA-MB-231 | A443654 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 726 | 4513 | 0.1609 | -0.1556 |
MDA-MB-231 | OSI-027 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3706 | 4513 | 0.8211 | 0.7537 |
MDA-MB-231 | XMD11-85h | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3933 | 4513 | 0.8715 | 0.8231 |
MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1998 | 4513 | 0.4428 | 0.2327 |
MDA-MB-231 | WH-4-025 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1296 | 4513 | 0.2871 | 0.0183 |
MDA-MB-231 | WZ-4-145 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3218 | 4513 | 0.7131 | 0.6049 |
MDA-MB-231 | XMD16-144 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1462 | 4513 | 0.3239 | 0.0690 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4187 | 4513 | 0.9276 | 0.9003 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3987 | 4513 | 0.8835 | 0.8395 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2132 | 4513 | 0.4724 | 0.2735 |
MDA-MB-231 | Canertinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4023 | 4513 | 0.8915 | 0.8505 |
MDA-MB-231 | Celastrol | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3589 | 4513 | 0.7953 | 0.7181 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 521 | 4513 | 0.1154 | -0.2181 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 459 | 4513 | 0.1017 | -0.2370 |
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3731 | 4513 | 0.8267 | 0.7613 |